Cargando…
TI nulling and contrast conditions with a 0.15 mmol/kg dosage of MultiHance as compared to the standard 0.2 mmol/kg gadolinium dosage in patients with myocardial infarcts
Autores principales: | Yamrozik, June A, Doyle, Mark, Rathi, Vikas K, Vido, Diane A, Williams, Ronald B, Rayarao, Geetha, Biederman, Robert WW |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860797/ http://dx.doi.org/10.1186/1532-429X-11-S1-P189 |
Ejemplares similares
-
Breast lesion detection and characterization with contrast‐enhanced magnetic resonance imaging: Prospective randomized intraindividual comparison of gadoterate meglumine (0.15 mmol/kg) and gadobenate dimeglumine (0.075 mmol/kg) at 3T
por: Clauser, Paola, et al.
Publicado: (2018) -
Validation of early myocardial gadolinium enhancement (EGE) evaluation with "Lake Louise consensus" criteria in patients with suspected myocarditis using a single bolus of 0.1 mmol/Kg of a high relaxivity gadolinium-based contrast agent
por: Galea, Nicola, et al.
Publicado: (2015) -
Evaluation of the Recommended 30 cc/kg Fluid Dose for Patients With Septic Shock and Hypoperfusion With Lactate Greater Than 4 mmol/L
por: Yohannes, Seife, et al.
Publicado: (2023) -
MultiHance as a contrast alternative for Gadovist allergic patients
por: Malone, Janna, et al.
Publicado: (2020) -
Use of Lifestyle Modifications for Management of a Patient with Severely High Total Cholesterol (> 14 mmol/L) and Triglycerides (> 40 mmol/L)
por: Patel, Janhavi, et al.
Publicado: (2021)